Tau positron emission tomographic imaging in aging and early <scp>A</scp> lzheimer disease

2015993 citationsJournal Articlebronze Open Access

Authors

Keith A. Johnson · Harvard University

Aaron P. Schultz · Athinoula A. Martinos Center for Biomedical Imaging

Rebecca A. Betensky · Massachusetts General Hospital

J. Alex Becker · Massachusetts General Hospital

Jorge Sepulcre · Harvard University

Dorene M. Rentz · Brigham and Women's Hospital

Elizabeth C. Mormino

Abstract

These findings suggest that (18)F T807 PET could have value as a biomarker that reflects both the progression of AD tauopathy and the emergence of clinical impairment.

Topics & Keywords

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Functional Brain Connectivity Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Neurology

Volume 79, Issue 1, pp. 110-119

DOI: 10.1002/ana.24546

Field-Weighted Citation Impact: 56.89